Shares of BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) rose 4.5% on Tuesday . The stock traded as high as $1.90 and last traded at $1.85. Approximately 13,494 shares were traded during trading, a decline of 85% from the average daily volume of 87,537 shares. The stock had previously closed at $1.77.
BeyondSpring Trading Up 2.2 %
The firm’s 50 day simple moving average is $2.13 and its two-hundred day simple moving average is $2.23.
Hedge Funds Weigh In On BeyondSpring
A hedge fund recently bought a new stake in BeyondSpring stock. SG Americas Securities LLC bought a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 17,539 shares of the company’s stock, valued at approximately $63,000. Hedge funds and other institutional investors own 40.29% of the company’s stock.
About BeyondSpring
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Recommended Stories
- Five stocks we like better than BeyondSpring
- Insider Trading – What You Need to Know
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Plot Fibonacci Price Inflection Levels
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is Short Interest? How to Use It
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
